Literature DB >> 26579937

Nucleosomes Inhibit Cas9 Endonuclease Activity in Vitro.

John M Hinz1, Marian F Laughery1, John J Wyrick1.   

Abstract

During Cas9 genome editing in eukaryotic cells, the bacterial Cas9 enzyme cleaves DNA targets within chromatin. To understand how chromatin affects Cas9 targeting, we characterized Cas9 activity on nucleosome substrates in vitro. We find that Cas9 endonuclease activity is strongly inhibited when its target site is located within the nucleosome core. In contrast, the nucleosome structure does not affect Cas9 activity at a target site within the adjacent linker DNA. Analysis of target sites that partially overlap with the nucleosome edge indicates that the accessibility of the protospacer-adjacent motif (PAM) is the critical determinant of Cas9 activity on a nucleosome.

Mesh:

Substances:

Year:  2015        PMID: 26579937     DOI: 10.1021/acs.biochem.5b01108

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  51 in total

1.  Evaluation and rational design of guide RNAs for efficient CRISPR/Cas9-mediated mutagenesis in Ciona.

Authors:  Shashank Gandhi; Maximilian Haeussler; Florian Razy-Krajka; Lionel Christiaen; Alberto Stolfi
Journal:  Dev Biol       Date:  2017-03-22       Impact factor: 3.582

2.  Nucleosomes Selectively Inhibit Cas9 Off-target Activity at a Site Located at the Nucleosome Edge.

Authors:  John M Hinz; Marian F Laughery; John J Wyrick
Journal:  J Biol Chem       Date:  2016-10-18       Impact factor: 5.157

Review 3.  Genome editing in cardiovascular diseases.

Authors:  Alanna Strong; Kiran Musunuru
Journal:  Nat Rev Cardiol       Date:  2016-09-09       Impact factor: 32.419

4.  CRISPR-Cas12a has widespread off-target and dsDNA-nicking effects.

Authors:  Karthik Murugan; Arun S Seetharam; Andrew J Severin; Dipali G Sashital
Journal:  J Biol Chem       Date:  2020-03-11       Impact factor: 5.157

5.  Massively parallel kinetic profiling of natural and engineered CRISPR nucleases.

Authors:  Stephen K Jones; John A Hawkins; Nicole V Johnson; Cheulhee Jung; Kuang Hu; James R Rybarski; Janice S Chen; Jennifer A Doudna; William H Press; Ilya J Finkelstein
Journal:  Nat Biotechnol       Date:  2020-09-07       Impact factor: 54.908

6.  BEON: A Functional Fluorescence Reporter for Quantification and Enrichment of Adenine Base-Editing Activity.

Authors:  Peipei Wang; Li Xu; Yandi Gao; Renzhi Han
Journal:  Mol Ther       Date:  2020-04-16       Impact factor: 11.454

Review 7.  Lessons from Enzyme Kinetics Reveal Specificity Principles for RNA-Guided Nucleases in RNA Interference and CRISPR-Based Genome Editing.

Authors:  Namita Bisaria; Inga Jarmoskaite; Daniel Herschlag
Journal:  Cell Syst       Date:  2017-01-25       Impact factor: 10.304

Review 8.  Examination of CRISPR/Cas9 design tools and the effect of target site accessibility on Cas9 activity.

Authors:  Ciaran M Lee; Timothy H Davis; Gang Bao
Journal:  Exp Physiol       Date:  2017-04-12       Impact factor: 2.969

9.  Modulating Gene Expression in Epstein-Barr Virus (EBV)-Positive B Cell Lines with CRISPRa and CRISPRi.

Authors:  Liang Wei Wang; Stephen J Trudeau; Chong Wang; Catherine Gerdt; Sizun Jiang; Bo Zhao; Benjamin E Gewurz
Journal:  Curr Protoc Mol Biol       Date:  2018-01-16

Review 10.  Genome Editing with CRISPR-Cas9: Can It Get Any Better?

Authors:  Maximilian Haeussler; Jean-Paul Concordet
Journal:  J Genet Genomics       Date:  2016-04-24       Impact factor: 4.275

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.